KW, J., MA, M., & JS, H. (2024). Ocular Effects of MEK Inhibitor Therapy: Literature Review, Clinical Presentation, and Best Practices for Mitigation. The oncologist, 29(5), e616. https://doi.org/10.1093/oncolo/oyae014
Chicago Style (17th ed.) CitationKW, Jeng-Miller, Miller MA, and Heier JS. "Ocular Effects of MEK Inhibitor Therapy: Literature Review, Clinical Presentation, and Best Practices for Mitigation." The Oncologist 29, no. 5 (2024): e616. https://doi.org/10.1093/oncolo/oyae014.
MLA (9th ed.) CitationKW, Jeng-Miller, et al. "Ocular Effects of MEK Inhibitor Therapy: Literature Review, Clinical Presentation, and Best Practices for Mitigation." The Oncologist, vol. 29, no. 5, 2024, p. e616, https://doi.org/10.1093/oncolo/oyae014.
Warning: These citations may not always be 100% accurate.
